This acquisition establishes Niagen Bioscience as the sole owner of the most comprehensive and defensible intellectual property portfolio in the NAD+ industryLOS ANGELES--(BUSINESS WIRE)--$NAGE ...

Niagen Bioscience ( ($NAGE) ) has shared an update. On December 16, 2025, Niagen Bioscience’s subsidiary ChromaDex, Inc. entered into an ...

Niagen Bioscience (NAGE) is grabbing attention after two major announcements: positive clinical trial results for its patented Niagen ingredient in long COVID, and the debut of Tru Niagen Beauty, ...

The desire for youth and longevity is ubiquitous, with doctors, consumer product formulators, and infomercial hosts rushing to crack the aging code. Heck, even Cher once wished she could turn back ...

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced the launch of Tru Niagen® Beauty, ...

This science-backed blend of Niagen and clinically studied actives is designed to support healthy skin, hair, and nails Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ ...

This science-backed blend of Niagen and clinically studied actives is designed to support healthy skin, hair, and nails “Niagen has changed how the world thinks about cellular health,” said Rob Fried, ...

LOS ANGELES, November 13, 2025--(BUSINESS WIRE)--Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, ...

Niagen Bioscience Inc beats earnings expectations. Reported EPS is $0.05, expectations were $0.015. Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Niagen Biosciences, ...